Pharmaceutical manufacturer Quantum Pharma has appointed Buchanan as the group’s financial PR and investor relations adviser.
Quantum entered the London Stock Exchange’s AIM market in December 2014. It operates three divisions; Specials, Niche Pharmaceuticals and Medication Adherence.
Buchanan‘s Henry Harrison-Topham will lead the account, supported by partner Mark Court, account director Sophie Cowles, and account manager Steph Watson. The team will work closely with CEO Andrew Scaife, CFO Martin Such and Craig Swinhoe, the group’s legal and projects director.
Harrison-Topham said: “We are delighted to have been appointed by Quantum Pharma, which is well positioned for growth with its exciting product pipeline, and development and manufacturing infrastructure. Buchanan has an established depth of expertise in the healthcare sector and we look forward to working with Quantum Pharma to build awareness of its attractive investment case.”